GlassScriptPhysician profile
Beth A Aughenbaugh
NPI 1962795666
$1,952.48
in general payments reported to CMS, 2019-2025
21 companies · $71.82 in 2025
The $71.82 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.76 · 2022: $23.71 · 2023: $802 · 2024: $1,034 · 2025: $71.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,843 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,843.01 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $547.39 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $317.37 | 2023-2024 | Xtandi, Myrbetriq |
| Davol INC. | $183.94 | 2023-2024 | Arista Ah Flexitip |
| Tolmar, INC. | $136.01 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $131.97 | 2023-2024 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $80.32 | 2024 | Adstiladrin |
| Procept Biorobotics Corporation | $76.87 | 2024 | Aquabeam System |
| Pfizer INC. | $59.49 | 2023-2024 | |
| Antares Pharma, INC. | $58.65 | 2024 | Xyosted |
| Olympus America INC. | $52.80 | 2023-2025 | Itind System, Soltive |
| Eisai INC. | $45.35 | 2023-2024 | |
| Pinnacle Biologics, INC | $44.47 | 2021-2022 | |
| Janssen Biotech, INC. | $41.46 | 2023-2025 | Erleada |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.90 | 2023 | Lifevest |
| Dendreon Pharmaceuticals LLC | $27.14 | 2024 | Provenge |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $22.60 | 2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $18.84 | 2023 | |
| Calyxo, INC. | $17.77 | 2024 | Cvac Aspiration System |
| Genzyme Corporation | $17.64 | 2023 | |
| Abbvie INC. | $17.50 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $16.00 | 2024 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Aughenbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.